2017 International Congress Archives - Page 53 of 155

A case of Dementia with Lewy Bodies Co-Occuring with Multiple Sclerosis

A. Hannoun, E. DeGrush, K. Smith, T. Kao, A. Deb (Worcester, MA, USA)
A case of idiopathic adult-onset truncal extension dystonia treated with bilateral pallidal deep brain stimulation

D. Ehrlich, S. Frucht, B. Kopell, P. Greene, R. Ramdhani (New York, NY, USA)
A case report: a primary progressive multiple sclerosis (PPMS) with adolescent-onset of progressive cerebellar ataxia

S.-K. Yang, J.-J. Lin (Changhua county, Taiwan)
A combined cognitive and motor exercise program for people with Parkinson’s disease and Freezing of gait; a pilot study.

L. King, K. Smulders, M. Mancini, J. Lapidus, P. Carlson-Kuhta, B. Fling, J. Nutt, F. Horak (Portland, OR, USA)
A comparative study between OCT in SCA3 and 10

F. Tensini, M. Sato, N. Shiokawa, H. Teive (Curitiba, Brazil)
A Comparison of Muscular Atrophy Between Botulinum Toxin Types A and B

F. Amjad, F. Pagan, A. Lax, C. Moussa (Washington DC, DC, USA)
A Comparison of Temporal Discrimination Thresholds in Musicians with and without Dystonia

O. Killian, K. Simonyan, E. McGovern, B. Quinlivan, S. Narasimham, I. Beiser, J. Butler, R. Beck, S. O'Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)
A Descriptive Analysis of a Real-World Population With Huntington Disease-Associated Chorea (HDAC) Treated With Tetrabenazine: Findings From an Electronic Medical Records (EMR) Database

R. Iver, D. Alevras, S. Gandhi, T. Schilling, V. Abler, F. Cao, K. Johnson, K. Anderson (Frazer, PA, USA)
A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)
A follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease and atypical parkinsonian syndrome

J. Horie, H. Fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Matsubara, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)
A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease

A. Sauerbier, L. Klingelhoefer, R. Banerjee, S. Diaconu, R. Erro, T. Farombi, S. Gangadharan, A. Macerollo, L. Chahine, O. Jitkritsadakul, R. Biundo, M. Grilo, H. Dafsari, G. Pagano, F. Niccolini, N. Titova (London, United Kingdom)
A kinematic analysis of finger tapping in dystonia

R. Newby, S. Muhamed, S. Smith, J. Alty, S. Jamieson, P. Kempster (Melbourne, Australia)
A long-term study on effectiveness of levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease patients

K.R. Chaudhuri, A. Antonini, W. Poewe, D. Standaert, P. Odin, J. Zamudio, L. Bergmann (London, United Kingdom)
A member of the HSP40/DNAJ family is a novel gene for early-onset parkinsonism

L. Straniero, I. Guella, V. Rimoldi, L. Parkkinen, A. Young, R. Asselta, J. Follett, G. Soldà, E. Saba, V. Sossi, J. Stoessl, K. Nishioka, N. Hattori, A. Rajput, R. Cilia, S. Goldwurm, M. Farrer, G. Pezzoli, A. Rajput, S. Duga (Rozzano-Milano, Italy)
A model community neurofitness and wellness center for people with Parkinson disease. 1-year group pilot data

E. Borchers, B. Farley, D. Snider, T. McIsaac, J. Bazan-Wigle (Tucson, AZ, USA)
A modified model for prediction of Huntington disease age of onset based on length of CAG repeat expansion

Y. Seliverstov, E. Shulgina, S. Illarioshkin, M. Belyaev (Moscow, Russian Federation)
A national Swedish self-management program for people with Parkinson’s disease – patients and relatives view

C. Hellqvist, C. Berterö, M. Levander, N. Dizdar, P. Hagell (Linköping, Sweden)
A neuroimaging-based model for disease progression in Parkinson’s disease

N. Shenkov, I. Klyuzhin, A. Rahmim, V. Sossi (Vancouver, BC, Canada)
A neuronal model of PARK20 (SYNJ1 mutation) using patient derived iPSCs

R. Masius, M. Minneboo, M. Grochowska, M. Quadri, M. Picillo, P. Barone, V. Bonifati, W. Mandemakers (Rotterdam, Netherlands)
A new aroma in the new world

H. Fajardo, A. Medina, P. Gomez, r. Medina (tegucigalpa, Honduras)
A new neurophysiological tool for differential diagnosis in tremor syndromes: The Tremor Stability Index

L. di Biase, J.-S. Brittain, S.A. Shah, D.J. Pedrosa, H. Cagnan, A. Mathy, C.C. Chen, L. Timmerman, P. Schwingenschuh, K. Bhatia, V. Di Lazzaro, P. Brown (Oxford, United Kingdom)
A new psychosocial intervention for people with Parkinsonian dementias: Adherence, barriers and facilitators

S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)
A novel cause for unpredictable response to levodopa

J. Staisch, G. Bakis, J. Nutt (Portland, OR, USA)
A Novel Deep Brain Stimulation Programming Paradigm for Essential Tremor

J. Karl, L. Verhagen (Chicago, IL, USA)
A Novel Deep Brain Stimulation Programming Paradigm for Parkinson’s disease

J. Karl, L. Verhagen, D. Ocegueda (Chicago, IL, USA)
A Novel Model of Care for Advanced Parkinson’s Disease and Related Disorders: Interdisciplinary Home Visits

J. Fleisher, W. Barbosa, M. Sweeney, S. Oyler, A. Lemen, A. Fazl, M. Ko, T. Meisel, N. Friede, G. Dacpano, R. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)
A novel paradigm of variable frequency deep brain stimulation to improve freezing of gait in Parkinson’s disease

F. Jia, A. Wagle Shukla, w. Hu, L. Almeida, M. Okun, L. Li (Beijing, China)
A Pair of Brothers with Aceruloplasminemia Due to a Novel Nonsense Mutation: Unusual Phenotype and Neurological Improvement After Iron-Chelation Therapy with Deferasirox.

F. Valzania, F. Cavallieri, M. Fiorini, S. Contardi, F. Ferrara, E. Menozzi, S. Scarlini, F. Cavalleri, M. Molinari, A. Pietrangelo, E. Corradini (Modena, Italy)
A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations

S. Ramaswamy, W. Wen, G. Ramaswamy, L. Friedhoff (New York, NY, USA)
A Phase 2, Open-Label, Dose-Escalating Study to Evaluate the Safety and Preliminary Efficacy of Daxibotulinumtoxina for Injection (RT002) in Isolated Cervical Dystonia

C. Comella, J. Jankovic, D. Truong, A. Brashear, A. Patel, M. Evatt, C. Chung, R. Rubio (Chicago, IL, USA)
A Phase 3 Study of isradipine as a disease modifying agent in patients with early Parkinson’s disease (STEADY-PD III): Baseline characteristics and study update

K. Biglan, J. Lowell, D. Oakes, K. Hodgeman, R. Rockhill, B. Greco, R. Holloway, T. Simuni (Rochester, NY, USA)
A Pilot Multiparametric MEG Study of coherence in generalized and cervical dystonia

A. Mahajan, S. Bowyer, A. Zillgitt, P. LeWitt, P. Kaminski, C. Sidiropoulos (Detroit, MI, USA)
A pilot study of mindfulness yoga on psychological distress in people with Parkinson’s Disease (PD)

JJ.Y.-Y. Kwok, J.C.-y. Kwan, H.Y.-L. Chan (Hong Kong, Hong Kong)
A Preliminary Study: Validity and Reliability of Parkinson Fatigue Scale (PFS) in Turkish Patients with Parkinson’s Disease (PD)

E. Ozturk, E. Ozturk, B. Gonenli Kocer, I. Gundogdu, A. Cakci, E. Umay (Ankara, Turkey)
A Preliminary Study: Validity and Reliability of Turkish Version of Fatigue Severity Scale (FSS) in Patients with Parkinson’s Disease (PD)

E. Ozturk, B. Gonenli Kocer, I. Gundogdu, A. Cakci, E. Umay (Ankara, Turkey)
A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD

H.-L. Chiang, F. Chang, D. Tsui, Y. Tai, A. Ha, N. Mahant, J. Griffith, D. Galea, S. Kim, B. Cruse, H. Morales-Briceño (New Taipei City, Taiwan)
A prospective randomized cross-over study of telemedicine system in Parkinson’s disease

S. Sekimoto, G. Oyama, T. Hatano, F. Sasaki, R. Nakamura, T. Jo, Y. Shimo, N. Hattori (Tokyo, Japan)
A PSP-like phenotype accompanies rapidly progressive dementia

M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)
A qualitative study of the views and experience of people with Parkinson’s disease regarding their footwear

A. Ashburn, M. Donnovan-Hall, J. Robison, M. Cole, C. Bowen, M. Burnett, L. Mamode, R. Pickering, D. Bader, D. Kunkel (Southampton, United Kingdom)
A quantitative meta-analysis study of Impulse control disorders in patients with and without Parkinson’s Disease.

A. Faust- Socher, M. Criaud, A. Mihaescu, A. Lang, S. Cho, S. Houle, A. Strafella (Toronto, ON, Canada)
A randomised control trial to investigate if people with Parkinson’s disease can exercise at high intensity, and does this improve their cardiorespiratory function? A feasibility study

M. Harvey, R. Walker, W. Gray, K. Weston, L. Oates (North Shields, United Kingdom)
A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome

D. Gilbert, T. Murphy, J. Jankovic, C. Budman, K. Black, R. Kurlan, K. Coffman, J. McCracken, J. Juncos, J. Grant, R. Chipkin (Cincinnati, OH, USA)
A registry study of multiple system atrophy in Hokkaido, Japan: HoRC-MSA Project 2014-16

M. Matsushima, K. Sakushima, I. Yabe, Y. Kanatani, Y. Ito, T. Matsuoka, T. Katayama, H. Uesugi, K. Sako, A. Takei, M. Mori, S. Shimohama, N. Sato, S. Kikuchi, H. Sasaki (Sapporo, Japan)
A retrospective analysis of clinical forms and age of onset of biallelic Huntington disease patients from an Argentinean Center

M. Cesarini, V. Parisi, G. Persi, J. Etcheverry, A. Sanguinetti, F. Squitieri, E. Gatto (Buenos Aires, Argentina)
A review of telemedicine for Parkinson’s disease: But what’s happen in Asia??

W. Rattanachaisit, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
A Service Evaluation of the Clinical Use of Parkinson’s KinetiGraph (PKG) Movement Recording System in the Assessment of Parkinson’s Disease Patients with Tremor

J. Price, H. Martin, L. Ebenezer (Bronllys, United Kingdom)
A single aerobic exercise session of treadmill increases BDNF levels in Parkinson’s disease patients

P. Scalzo, L. Dos Santos, J. Pereira, R. Santos, N. Rocha, A. Texeira, P. Christo (Belo Horizonte, Brazil)
A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)

R. Pyda, A. Hohler (Boston, MA, USA)
A Swedish family with Paroxysmal Kinesigenic Dyskinesia due to p.Arg217Profs*8 truncation in the proline-rich transmembrane protein 2 gene

P. Tsitsi, M. Paucar Arce, P. Svenningsson (Stockholm,, Sweden)
a-synuclein neurotoxicity and spreading using Lewy Body extracts from Parkinson Disease Brains: In vitro screening by cell-based assays

E. Bezard, F. Cavaliere, L. Cerf, B. Dehay, P. Ramos-Gonzalez, F. De Giorgi, M. Bourdenx, A. Bessede, J. Obeso, F. Ichas, C. Matute (Bordeaux, France)
AAV-mediated human alpha synuclein overexpression in the locus coeruleus (LC) leads to a neuronal loss in the nucleus ambiguus of mouse.

B. Lee, M. Henrich, W.-H. Chiu, L. Matschke (Marburg, Germany)
AAV-mediated over-expression of VEGF-B in PINK1 gene knockout rats increases striatal dopamine content

T. Falk, M. Bartlett, D. Muller, B. Silashki, D. Farrell, K. Parent, M. Heien, S. Sherman (Tucson, AZ, USA)
Aberrant resting state functional brain networks in patients with Parkinson’s disease and visual hallucinations

A. Lenka, R. Panda, L. George, S. Hegde, S. Arumugham, J. Saini, R. Bharath, P. Pal (Bangalore, India)
Abnormal activity in reward system in Parkinson’s disease patients with rapid eye movement sleep behavior disorder

C. BEAL, M.L. FANTINI, G. SESCOUSSE, M. ULLA, C. CHASSAIN, A. Marques, B. Pereira, N. VITELLO, P. BEUDIN, R. Colamarino, F. DURIF (Clermont-Ferrand, France)
Abnormal DaTscan in a case of Anoxic brain injury

S. Byreddy, U. Zahid, H. Lei (Tucson, AZ, USA)
Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, A. Numao, H. Fujita, Y. Watanabe, T. Matsubara, M. Miyamoto, K. Kaga, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)
Abnormal patterns of action selection in the dominant motor cortex in writer’s cramp

A. Kishore, S. Meunier, P. James, S. Krishnan, T. Popa (Trivandrum, India)
Abnormal spontaneous activity and functional connectivity in patients with Parkinson’s disease with anxiety

M. Criaud, M. Zurowski, N. Lobaugh, S. Chavez, Y. Koshimori, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)
Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)
Accuracy measures of imbalance bedside examination

y. xia, R. Thompson, D. Bhatti, A. Hellman, J. McKune, K. Suing, L. Schmaderer, K.-C. Siu, D. Torres-Russotto (omaha, NE, USA)
Acquisition, Validation and Preprocessing of Wrist-Worn Sensor Data in Patients with Parkinson’s Disease and Healthy Controls

D. Pichler, M. Lang, D. Kulić, F. Pfister, G. König, T. Um, A. Ahmadi, S. Endo, F. Achilles, K. Abedinpour, K. Bötzel, A. Ceballos-Baumann, S. Hirche, U. Fietzek (Munich, Germany)
Action Observation Training Effects on Brain Structural and Functional Changes in Parkinson’s Disease Patients

E. Sarasso, F. Agosta, M. Di Meo, M. Giacobbe, M.A. Volonté, G. Comi, A. Tettamanti, R. Gatti, M. Filippi (Milan, Italy)
Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations

K. Nozile-Firth, V. Viswanathan, K. Foote, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)
Action Verb Generation as a marker of cognitive function in Parkinson disease

O. Yerokhin, K. Smith (Worcester, MA, USA)
Action Verbal Fluency is Related to the Functional Integrity of the Cognitive Cortico-Striatal Loop in Parkinson’s Disease

N. Auclair-Ouellet, A. Hanganu, E. Mazerolle, J. Sarna, M. Kibreab, J. Cheetham, I. Kathol, A. Haffenden, B. Pike, O. Monchi (Calgary, AB, Canada)
Active Arms: a randomized controlled trial of an interactive videogame for people with Parkinson’s disease

N. Allen, J. Song, S. Paul, S. Smith, J. O'Duffy, M. Schmidt, R. Love, C. Sherrington, C. Canning (Lidcombe, Australia)
Acute L-dopa Challenge Test In Early Parkinsonism With Respect To Presence Of Red Flag Signs &MRIAbnormalitis

M. ACHARYA, A. BISWAS, A. Chatterjee, S. DAS (KOLKATA, India)
Adding cues to a rat gambling task potentiates the increase in premature responding in response to chronic D2/3 agonist ropinirole without mitigating preference for risk

M. Tremblay, M. Barrus, P. Cocker, S. Kaur, C. Winstanley (Vancouver, BC, Canada)
Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Efficacy, Safety, and Tolerability of Fixed-Dose Deutetrabenazine for the Treatment of Tardive Dyskinesia

K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, J. Jimenez-Shahed, W. Ondo, H. Fernandez (Washington, DC, USA)
Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Improvements in Clinical Global Impression of Change (CGIC) with Deutetrabenazine Treatment in Tardive Dyskinesia (TD)

J. Jimenez-Shahed, H. Fernandez, R. Hauser, M. Davis, S. Factor, J. Isojärvi, W. Ondo, D. Stamler, K. Anderson (Houston, TX, USA)
Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey

S. Gupta, F. Benesh, V. Sung (Birmingham, AL, USA)
Admixing augments nigral dopaminergic correlates during development to impart resistance to MPTP-toxicity at adulthood

V. D J, Y. H, R. T R, P. Anand Alladi (Bangalore, India)
Advance care planning in advanced Parkinsonian patients in a long-term care hospital

M.-J. Kim, H.J. Kim, J.-K. Kim, H.-R. Na, S.-B. Koh (Seoul, Republic of Korea)
Advanced DBS programming – Multiple Groups : 3yrs experience

g. hosurkar, r. gopalakrishnan (Bengaluru, karnataka, India)
Aerobic Exercise Combined with rTMS for Parkinson’s Disease: A Randomized Trial

H. Migdadi, M. Biagioni, S. Agarwal, A. Cucca, P. Kumar, A. Quartarone, R. Rossi, M. Ghilardi, A. Di Rocco (New York, NY, USA)
Alien Limb Syndrome Induced by a Dopamine Agonist in a Patient with Parkinsonism and Agenesis of the Corpus Callosum

M. Krause, J. Shou, S. Joy, D. Torres-Russotto (Omaha, NE, USA)
All-trans-retinoic Acid pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced hemi-parkinsonian rats

A. Morad Ganjeh (Karaj, Islamic Republic of Iran)
Allelic CACNA1A disorders: a retrospective cohort analysis on clinical course and overlapping features

W. Nachbauer, P. Dorin, E. Indelicato, A. Eigentler, S. Boesch (Innsbruck, Austria)
Alpha-synuclein enhances histone H3 lysine-9 dimethylation

N. Sugeno, S. Jäckel, A. Voigt, T. Hasegawa, P. Kahle (Tübingen, Germany)
Alpha-Synuclein knock-out mouse brain shows significant dysregulation of c-Fos expression

M. Overhoff, J. Canet-Pons, D. Meierhofer, S. Gispert, G. Auburger (Frankfurt am Main, Germany)
Alpha-synuclein protein homeostasis and oligomerization in iron-overloaded cells expressing mutant HFE

Y. Kim, J. Connor, M. Stahl (Hershey, PA, USA)
Alpha-synucleinopathy and mitochondrial dysfunction in a cell based model of neurodegeneration: Implications in the pathogenesis of sporadic Parkinson’s disease

U. Ganguly, O. Sen, A. Ganguly, S. Chakrabarti (Kolkata, India)
Alteration of early endosomal trafficking causes neurodegeneration in PARK20

C. Criscuolo, D. Fasano, V. Coppola, G. Amodio, M. Picillo, A. De Rosa, V. Bonifati, P. Barone, M. Pellecchia, G. De Michele, P. Remondelli, S. Paladino (Naples, Italy)
Alterations in Dynamic Brain Connectivity Patterns in Parkinson’s Disease

X. Dan, A. Liu, J. Wang, M. McKeown, T. Wu, P. Chan (Beijing, China)
Alterations in lipid metabolism modify GBA1-mediated neurodegeneration in a Drosophila model of Parkinson’s disease

M. Davis, R. Thomas, A. Germanos, S. Yu, B. Whitley, L. Pallanck (Seattle, WA, USA)
Altered attentional brain network in Parkinson’s disease with mild cognitive impairment

J.H. Yang, K. McMahon, D. Copland, G. Byrne, A. Toft, L. Mithcell, J. O'Sullivan, N. Dissanayaka (Herston, Australia)
Altered brain network measures in patients with Primary Writing Tremor

A. Lenka, K. Jhunjhunwala, R. Panda, R. Yadav, J. Saini, R. Bharath, P. Pal (Bangalore, India)
Altered intrinsic brain functional connectivity in drug-naïve Parkinson’s disease with LRRK2 mutation

Y. Hou, C. Luo, J. Yang, R. Ou, W. Song, Y. Chen, Q. Gong, H. Shang (Chengdu, China)
Altered PDE10A Expression Detectable Early in Untreated Parkinson’s Disease Patients

G. Pagano, F. Niccolini, H. Wilson, T. Yousaf, N. Khan, D. Martino, R. Gunn, E. Rabiner, M. Politis (London, United Kingdom)
Altered Resting-State Functional Interhemispheric Connectivity in Parkinson’s Disease

X. Dan, S. Lin, A. Liu, J. Wang, T. Wu, P. Chan, M. McKeown (Beijing, China)
Altered somtatosensory cortex neuronal activity in a rat model of Parkinson`s disease and levodopa-induced dyskinesias

K. Schwabe, X. Jin, J. Krauss, M. Alam (Hannover, Germany)
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease

C.-M. Chen, K.-H. Chang, Y.-R. Wu, M.-L. Cheng (Taoyuan, Taiwan)
Alternative Apomorphine Challenge Test

J.C. Martinez Castrillo, A. Alonso Canovas, C. Estevez Fraga, G. Sanchez Diez, I. Avilés Olmos, J. Lopez Sendon, P. Garcia Ruiz, L. Vela Desojo (Madrid, Spain)
Ambulatory movement measurement in evaluating deep brain stimulation effect in patients with advanced Parkinson’s disease

M. Koivu, F. Scheperjans, E. Pekkonen (Helsinki, Finland)
An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson’s disease.

Y. Yamanishi, R. Ando, C. Yamasaki, S. Tada, N. Miyaue, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, M. Nomoto (Ehime, Japan)
An auditory biomarker for Parkinson’s Disease ?

K. De Keyser, A. Bockstael, D. Botteldooren, D. Talsma, M. De Letter, P. Santens (Ghent, Belgium)
An evaluation of the diagnostic utility of radiological biomarkers in PSP

J. Whitwell, G. Hoglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, R. Dodel, T. van Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Respondek, G. Rabinovici, J. Rowe, M. Stamelou, K. Josephs (Rochester, MN, USA)
An Evaluation of the Parkinson’s Kinetigraph (PKG) as a Tool to Support Deep Brain Stimulation Eligibility Assessment in Patients with Parkinson’s Disease

M. Horne, J. Volkmann, C. Sannelli, P.-P. Luyet, E. Moro (Parkville, Australia)
An MCID for AIMS Dyskinesia Total Score Change in Subjects with Tardive Dyskinesia

M. Stacy, R. Kurlan, J. Burke, S. Siegert, G. Liang, C. O'Brien (Durham, NC, USA)
An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN)

L. Meytin, T.-W. Liang (Philadelphia, PA, USA)
An unusual case of hemichorea in a woman with newly discovered renal cell carcinoma and inconclusive LGI-1 antibody

K. Colletta, N. Kartha, J. Chawla (Maywood, IL, USA)
An unusual case of sporadic Creutzfeld Jacob disease presenting as acute neuropathy

R. Hanumanthu, A. Alchaki, A. Nyaboga, H. Ghuman, J. Chen, E. Feinstein (Newark, NJ, USA)
An Unusual Cause of Rhabdomyolysis in Parkinson’s disease

Y. Pitakpatapee, C. Satukijchai, P. Srivanitchapoom (Bangkok, Thailand)
An unusual mimicker of Lewy Body Dementia: Gliomatosis Cerebri.

H. Oliveira, P. Oliveira, V. Calil, P. Macêdo, N. Canedo, L. Vasconcellos (Rio de Janeiro, Brazil)
An unusual presentation of tyrosine hydroxylase deficiency

L. Katus, S. Frucht (New York, NY, USA)
Analyses of physical activity on cognitive flexibility, depression and RBD in healthy elderly with high risk for neurodegenerative diseases

S. Lerche, A. Gutfreund, K. Brockmann, I. Wurster, G. Eschweiler, F. Metzger, W. Maetzler, D. Berg (Tuebingen, Germany)
Analysis of related factors of occurrence of dementia in Parkinson’s disease using the application form of Parkinson’s disease provided by the specific diseases treatment research program of Ministry of Health, Labor and Welfare of Japan

K. Konaka, M. Mihara, H. Mochizuki (Suita, Japan)
Analysis of serum non-mercaptoalbumin in patients with Parkinson’s disease

S. Ueno, T. Hatano, Y. Ouji, S. Saiki, H. Ikeda, N. Hattori (Tokyo, Japan)
Analysis of the exclusion causes for deep brain stimulation in Parkinson’s Disease Center in southern Taiwan

Y.-F. CHEN, Y.-F. CHEN, C.-C. CHANG, Y. LI, Y.-Y. CHANG (Kaohsiung, Taiwan)
Anatomical predictors of survival in PSP: thalamic collapse towards the end of life

W. Bevan-Jones, S. Jones, B. Ghosh, T. Rittman, I. Coyle-Gilchrist, J. Rowe (Cambridge, United Kingdom)
Anosognosia for Levododopa-induced Dyskinesias in PD – Frequency

R. Doyle Maia, F. Cardoso, P. Caramelli (Vitória, Brazil)
Anti-synuclein alpha antibodies and IL-1β at Parkinson Disease (PD).

A. Boika, V. Ponomarev, H. Ivanchik (Minsk, Belarus)
Antibody binding differences in alpha-synuclein from Parkinson’s disease and multiple system atrophy

T. Yamasaki, A. Welleford (Lexington, KY, USA)
Antibody-Induced Failure of Botulinum Toxin Therapy: Restart with Incobotulinumtoxina Offers a New Opportunity

D. Dressler, F. Adib Saberi (Hamburg, Germany)
Antiparkinson and antioxidant effect of N-Methanesulfonylpyrazolinyl substituted Heterosteroids in LPS induced Neuroinflammation Model of Rats

R. Singh (Chandigarh, India)
Antiphospholipid syndrome presenting with craniocervical dystonia: A case study

C. Dietiker, C. Clelland, S. Gupta, M. Richie, M. Shah, I. Bledsoe (San Francisco, CA, USA)
Antisense FMR1 splice variant and loss of AGG interruptions are predictors of Fragile X-associated tremor/ataxia syndrome (FXTAS)

P. Vittal, S. Pandya, K. Sharp, E. Berry-Kravis, L. Zhou, B. Ouyang, J. Jackson, D. Hall (Winfield, IL, USA)
Antisense oligonucleotides containing amido-bridged nucleic acid downregulate SNCA expression and improve motor function in Parkinson’s disease mouse models.

T. Uehara, C.-J. Choong, H. Hayakawa, Y. Kasahara, T. Nagata, T. Yokota, K. Baba, M. Nakamori, S. Obika, H. Mochizuki (Suita-Shi, Osaka, Japan)
Anxiety influences the neural correlates associated with freezing of gait in Parkinson’s disease

K. Ehgoetz Martens, M. Georgiades, M. Gilat, J. Hall, J. Shine, C. Walton, S. Lewis (Camperdown, Australia)
Apathy in adolescents with Tourette syndrome (TS), more than a teenager attitude

W. Deeb, M. Hensley, A. Bernier, I. Malaty (Gainesville, FL, USA)
APOE4+ status increases rate of longitudinal cognitive decline in Parkinson Disease patients with low CSF Aβ42

K. Leaver, T. Hendershott, D. Zhu, L. Tian, K. Poston (Stanford, CA, USA)
Apolipoprotein E ε4 allele frequency in Korean Patients with Parkinson’s disease Dementia

M. Park (Daegu, Republic of Korea)
Apomorphine infusion does not impair cognitive action control in Parkinson’s disease

J. Duprez, J.-F. Houvenaghel, S. Drapier, D. Drapier, M. Vérin, P. Sauleau (Rennes, France)
Application of a Qualitative Model to Elucidate the Role of the Alpha-Synuclein System in Parkinson’s Disease.

C. Friedrich, W. Zago, S. Gardai, G. Tonn, M. Reed (Cupertino, CA, USA)
Aquatic Dual Task Exercise: Effects on Body Balance of Individuals with Parkinson’s Disease

A. Silva, V. Israel (Curitiba, Brazil)
Aquatic Physical Exercises: Balance in People with Parkinson’s Disease

M. Ferreira, B. Yamaguchi, A. Silva, V. Israel (Curitiba, Brazil)
Are a „mathematical brain“ and early childhood adverse events possible risk factors that contribute to Progressive Supranuclear Palsy?

S. Lorenzl (Hausham, Germany)
Are patients with Parkinson’s disease who have either mild to moderate microsmia, severe microsmia or anosmia clinically different?

c. cox, A. Khattab, K. Amar (Bournemouth. Dorset, United Kingdom)
Are the exergaming effective for improving functional exercise capacity, and quality of life in Patients with Parkinson’s Disease?

C. Gemin, L. da Silva, M. Ribas Correa, H. Ghizone Teive, S. Valderramas (curitiba, Brazil)
Are there genotype-phenotype correlations in Perrys syndrome?

J. Panicker, M. Bonello, R. Ellis, A. Randall, L. Fratalia, S. Alusi (Liverpool, United Kingdom)
Ascertainment of Impaired Balance in Orthostatic Tremor Patients

D. Bhatti, R. Thompson, x. yiwen, A. Hellman, J. Mckune, L. Schmaderer, K. Suing, C. Penke, R. Iske, B.J. Roeder, K.-C. Siu, J. Bertoni, D. Torres-Russotto (Omaha, NE, USA)
Aspects of Quality of Life in MSA and PSP

L. Wiblin, M. Lee, D. Burn (Newcastle-upon-Tyne, United Kingdom)
Assessing Bone Health in Parkinson’s – When and how?

A. Dzharif, E. Thomas, B. Mohamed, T. Williams, S. Mahon (Cardiff, United Kingdom)
Assessing cholinergic innervation in Parkinson’s disease using the PET imaging marker [18F]Fluoroethoxybenzovesamicol

S. vander Zee, I. Alves, A. Willemsen, P. Elsinga, T. van Laar (Groningen, Netherlands)
Assessing Nigral Functional Connectivity in Parkinson’s Disease with Resting State Functional MRI

A. Martin-Bastida, Y. Xing, S. Pietracupa, A. Roussakis, N. Lao-Kaim, W. Li, X. Li, P. Mahlknecht, S. Schwarz, T. Foltynie, D. Auer, P. Piccini (London, United Kingdom)
Assessing Parkinson’s disease motor symptoms using supervised learning algorithms

P. Angeles, Y. Tai, N. Pavese, R. Vaidyanathan (London, United Kingdom)
Assessing the extent of carer strain in Parkinson’s disease

R. Varadarassou, V. Queen, E. Pearson, F. Murphy, M. Turner, C. Carroll (Plymouth, United Kingdom)
Assessing the involvement of ARSG and RAB12 variants in Musician’s Focal Dystonia from the US.

C. Stephen, M. Charness, K. Mangkalaphiban, T. Francoeur, A. Hamzehei-Sichani, S. Frucht, K. Simonyan, T. Multhaupt-Buell, N. Sharma, L. Ozelius (Boston, MA, USA)
Assessing the response to L-dopa/carbidopa intestinal gel infusion (Deudopa) based on genetic status.

A. Thaler, A. Hillel, H. Shabtai, N. Giladi, T. Gurevich (Tel-Aviv, Israel)
Assessment of Autonomic Dysfunction in Parkinson’s Disease

K. Karbozova, , (Bishkek, Kyrgyzstan)
Assessment of cognitive impairment using FP-CIT SPECT

N. Egawa, A. Kokuryu, Y. Inoue, A. Kuzuya, R. Takahashi (Kyoto, Japan)
Assessment of graphomotor impairment in patients with Spinocerebellar ataxia and Parkinson’s disease

M. Thomas, A. Stezin, A. Lenka, N. Thota, P. Pal, R. Yadav (Bengaluru, India)
Assessment of neurodegeneration and spreading of α-synuclein pathology induced by structurally defined α-synuclein assemblies in wild-type mice

E. Bezard, M. Bourdenx, L. Arcuri, L. Bousset, R. Melki, B. Dehay (Bordeaux, France)
Assessment of new technology in deep brain stimulation technology: what are the anticipated benefits?

C. Butson (Salt Lake City, UT, USA)
Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin (Madrid, Spain)
Assessment of substantia nigra degeneration with magnetic resonance and transcranial ultrasonography

C. Prieto, V. Suárez, C. Ordás, B. Venegas, R. Cazorla, A. Vinagre (Valdemoro, Spain)
Assessments of Movement Disorder Symptoms and Functional Impacts in Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

A. Bowden, S. Blair, K. Wesdock, M. Haller, M. Brandabur, P. Collins, A. Skrinar, J. Mayhew (Novato, CA, USA)
Assisted Suicide of patients with parkinsonian syndromes in Switzerland – the need of early and continuous integration of palliative care and dignitiy therapy

S. Lorenzl, L. Butzhammer, G. Nübling (Salzburg, Austria)
Associating patient impression of improvement with efficacy endpoints in Parkinson’s disease: A post-hoc analysis of a tozadenant study

C. Kenney, A. Glass, W. Olanow (Ardsley, NY, USA)
Association analyses of three susceptibility loci for Alzheimer’s disease in Parkinson’s disease, amyotrophic lateral sclerosis, and multiple system atrophy

Y. Chen, R. Ou, X. Chen, B. Cao, Q. Wei, B. Zhao, Y. Wu, H. Shang (Chengdu, China)
Association analysis of single nucleotide polymorphisms near the DYT3 locus to dystonic symptoms in X-linked dystonia-parkinsonism

G. Saranza, D. Sumalapao, A. Domingo, P. Pasco, R.D. Jamora, L. Lee, A. Westenberger, C. Klein (Manila, Philippines)
Association of arterial stiffness with cognition in patients with Lewy body disorder

J.Y. LEE, D.-W. Ryu, J.-S. Kim (Seoul, Republic of Korea)
Association of CSF biomarkers with motor and non-motor features in moderately advanced Parkinson’s disease cohort: the BioFIND study

J. Goldman, A. Amara, L. Shaw, P. Taylor, H. Andrews, R. Alcalay, T. Xie, P. Tuite, C. Henchcliffe, P. Hogarth, S. Frank, M.-H. Saint Hilaire, A. Naito, M. Frasier, V. Arnedo, A. Reimer, M. Sutherland, C. Swanson-Fischer, K. Gwinn, U. Kang (Chicago, IL, USA)
Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease

T. Nakamura, M. Suzuki, M. Ueda, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)
Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores

M. Leehey, S. Luo, S. Sharma, A.-M. Wills, J. Bainbridge, D. Simon, J. Schneider, Y. Zhang, A. Pérez, R. Dhall, C. Christine, C. Singer, F. Cambi (Aurora, CO, USA)
Association of nocturnal stridor with clinical features of patients with multiple system atrophy

H.-S. Ryu, J.-H. Paek, S. You, M.-J. Kim, Y.J. Kim, J. Kim, K. Kim, S.-A. Lee, S.J. Chung (Seoul, Republic of Korea)
Association of pain and depression with Parkinson’s disease-osteoarthritis comorbidity.

A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)
Association of pain in Parkinson’s disease with anxiety, depression and sleep quality: a cross-sectional study

A.Q. Rana, U. Saeed, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)
Association of Single Nucleotide Polymorphism in MAOB and Risk of Levodopa-Induced Dyskinesias in Parkinson’s Disease

B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)
Association of the GBA T369M polymorphism with motor and cognitive symptoms in Parkinson’s disease

A. Julius, Y.-H. Lin, M. Smith, J. Leverenz, D. Weintraub, J. Trojanoswski, V. Van Deerlin, B. Ritz, R. Rausch, J. Quinn, K. Chung, S. Factor, L. Rosenthal, T. Dawson, M. Albert, A. Espay, F. Revilla, J. Devoto, J. Goldman, G. Stebbins, B. Bernard, Z. Zbigniew, O. Ross, D. Dickson, D. Yearout, S.-C. Hu, C. Johnson, B. Cholerton, T. Montine, K. Edwards, C. Zabetian (Seattle, WA, USA)
Association of vitamin D deficiency in Parkinson disease

A. MUJTABA, N. ALSOMALI, A. ALSHAMRANI, S. MARAR, T. Alayan, J. BAJWA (RIYADH, Saudi Arabia)
Associations between Functional Networks and Temporal Discrimination Thresholds in Cervical Dystonia patients and their unaffected relatives

S. Narasimham, V. Sundararajan, E. McGovern, B. Quinlivan, I. Beiser, R. Beck, S. Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)
Associations of DAT SPECT and TCS with prodromal features of Parkinson’s disease: results in PREDICT-PD participants

A. Noyce, J. Dickson, J. Bestwick, I. Isaias, M. Politis, G. Giovannoni, T. Warner, A. Lees, A. Schrag (London, United Kingdom)
Associations of probable REM sleep behavior disorder, constipation, and hyposmia with PD

K. Hughes, X. Gao, J. Baker, M. Schwarzschild, A. Ascherio (Boston, MA, USA)
Astasia, reach and grasp deficits following bilateral medio-dorsal pulvinar lesions

M. Wilke, M. Baehr, I. Kagan, P. Dechent, Y. Cabral-Calderin, L. Schneider, A.-U. Dominguez-Vargas, K. Miloserdov, C. Schmidt-Samoa, H. Scherberger (Göttingen, Germany)
Asymmetric Orthostaic Myoclonus – A Case Series

Y.-c. Tai, J.-c. Tsou, S.-P. Hsu (Kaohsiung City, Taiwan)
Asymptomatic and transitory postoperative hypodense lesion around deep brain stimulation electrode

M. Sousa, F. Moreira, N. Canário, O. Brito, R. Pereira, M. Rito, C. Januário (Coimbra, Portugal)
Ataxia and increased cerebrospinal fluid phosphate associated with a mutation in the SLC20A2 gene

M. Paucar, H. Almqvist, V. Jelic, G. Hagman, G. Jörneskog, S. Holmin, I. Björkhem, P. Svenningsson (Stockholm, Sweden)
Ataxia asociated to neuromyelitis optica spectrum disorder

D. Pereira (Quezaltepeque, El Salvador)
Ataxia-Teleangiectasia-Mutated-Knock-Out mouse cerebellum shows significant reduction of calcium homeostasis factors

J. Canet-Pons, R. Schubert, U. Warnken, M. Schnoelzer, S. Zielen, G. Auburger (Frankfurt am Main, Germany)
Ataxia, opsoclonus and peripheral neuropathy induced by chronic toluene intoxication.

L. Beltrami, T. Araujo, C. Borges, F. Germiniani,, H. Teive (Curitiba, Brazil)
Atypical and slowly progressive FTDP-17 caused by MAPT p.R406W mutations – similarities to AD and PSP.

E. Ygland, D. van Westen, E. Englund, R. Rademakers, Z. Wszolek, K. Nilsson, C. Nilsson, O. Hansson, L. Gustafson, A. Puschmann (Lund, Sweden)
Audiological Evaluation in Sporadic Ataxia

B. Zeigelboim, H. Teive, A. Scheidt, K. Kronbauer, J. Faryniuk, T. Oliveira, F. Fernandes (Curitiba, Brazil)
Automated DBS Contact Selection using Coherence in Parkinson’s Disease

J. van Zijl, J. Elting, T. van Laar, F. Lange, G. Drost, D. Oterdoom, J. van Dijk, M. Tijssen, M. Beudel (Groningen, Netherlands)
Automated dosing schemes for administration of microtablets of levodopa for Parkinson’s disease, using wearable sensors

I. Thomas, F. Bergquist, D. Johansson, D. Nyholm, M. Memedi, J. Westin (Falun, Sweden)
Automatic discrimination between the striatum, Globus pallidus externa and Globus pallidus interna during deep brain stimulation surgery

D. Valsky, H. Bergman, Z. Israel (Jerusalem, Israel)
Autonomic Dysfunction in Early Parkinson’s Disease: Cross-Sectional Study in Hoehn and Yahr Stage 1

I. Stankovic, I. Petrovic, T. Pekmezovic, T. Stojkovic, V. Markovic (Belgrade, Serbia)
Autonomous Tracking of Body Bradykinesia during Unconstrained Activities in Parkinson’s Disease

S. Roy, B. Shiwani, J. Kline, M. Saint-Hilaire, C. Thomas, M. Gennert, G. De Luca (Natick, MA, USA)
Autosomal Dominant Spinocerebellar Ataxia Secondary to CACNA1G in a Patient of German Ancestry

E. Call, V. Santini (Stanford, CA, USA)
Availability of anti-Parkinsonian drugs in Thailand

K. Sakdisornchai, R. Bhidayasiri, O. Jitkritsadakul, p. panyakaew, J. Sringean (Bangkok, Thailand)
Axial Myoclonus in a Patient with PSP

R. Passo, T. Clark (Portland, OR, USA)
Axial signs in early-stage Parkinson’s disease : an influence of the genotype ?

G. BAILLE, D. DEVOS, V. HUIN, T. PEREZ, B. SABLONNIERE, L. DEFEBVRE, C. MOREAU (CHRU Lille, France)